by Infertility drugs are medications that help people who are experiencing infertility to conceive a child. Some common infertility drugs are clomiphene citrate, letrozole, and gonadotropins. Clomiphene citrate and letrozole are oral medications that help stimulate follicle development and increase egg production. Gonadotropins are injectable fertility medications that contain follicle-stimulating hormone (FSH) and/or luteinizing hormone (LH) to further stimulate and mature egg follicles. These drugs are usually used in conjunction with fertility treatments such as intrauterine insemination (IUI) or in vitro fertilization (IVF). IVF has been picking up pace worldwide as the successful treatment for infertility. During IVF, infertility drugs are administered to stimulate egg production and development before the eggs are manually retrieved for fertilization outside the body. Successful IVF cycles require well-developed mature eggs, which depends upon an optimal response to infertility medications.
The global Infertility Drugs Market is estimated to be valued at US$ 3699 million in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The increasing adoption of IVF treatments across the globe is expected to drive the growth of the infertility drugs market over the forecast period. As mentioned earlier, IVF is a highly successful treatment for infertility where drugs are administered before egg retrieval and fertilization. According to the World Health Organization, infertility affects approximately 8-12% of couples worldwide and IVF has helped millions of people battling infertility to conceive. Developed regions such as North America and Europe have witnessed increased IVF success rates in recent years which is creating high demand for infertility medications that enhance egg production and quality.
Another major driver for the market growth is increasing prevalence of infertility. Risk factors like advancing maternal age, obesity, lifestyle changes, genetic abnormalities and sexually transmitted infections are contributing to the rising infertility rates globally. This growing patient pool seeking effective treatment options will spur the demand for infertility drugs in the coming years.
Segment Analysis
The global infertility drugs market is segmented based on product type into ovulation stimulating drugs, female infertility drugs and male infertility drugs. Among these, the female infertility drugs segment dominates the market holding around 60% share owing to higher prevalence of female infertility. The drugs used for female infertility help in treatment of disorders causing infertility such as issues with ovulation, uterine fibroids and endometriosis.
PEST Analysis
Political: The market is positively impacted by supportive government initiatives and healthcare reforms in many countries aimed at increasing access to infertility treatment.
Economic: Rising income levels and healthcare spending have improved affordability of expensive infertility treatment globally. Strong economic growth in developing nations will augment market expansion in the coming years.
Social: Growing acceptance of assisted reproductive technologies and changing social trends including rising age of marriage and pregnancies are propelling the market growth.
Technological: Advancements in fertility procedures such as IVF, ICSI and egg/sperm freezing have increased success rates and expanded the potential patient pool, which is benefiting market revenue.
Key Takeaways
The Global Infertility Drugs Market Size is expected to witness high growth in the forecast period.
North America region currently dominates the market backed by growing assisted reproduction rates and rising cases of infertility due to late pregnancies and lifestyle changes. Key players operating in the infertility drugs market are Merck, Ferring Pharmaceuticals, LIVZON Pharmaceutical Group Inc., Abbott Laboratories and Bayer AG.
Key players operating in the infertility drugs market are Merck, Ferring Pharmaceuticals, LIVZON Pharmaceutical Group Inc., Abbott Laboratories and Bayer AG. Merck dominates the market with its large product portfolio for treating infertility disorders.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
